Will a clinical trial reporting weight-loss benefits of a GLP-1 agonist be published in a major medical journal in 2024?
➕
Plus
16
Ṁ1142
resolved Jan 7
Resolved
YES

The rise of GPL-1 agonists as "miracle" drugs to cure obesity, hypertension, and a myriad of social issues related to an unhealthy body mass has been nothing short of stunning -- as important as the development of AI. But we are just learning about the other potential effects of these. Will a new clinical trial at least confirm what we think we know about this class of drugs?

Get
Ṁ1,000
and
S3.00
Sort by:

I'm double-checking medical journals this week. It's not as straightforward as you might think. One of the two studies linked below was not published in 2024 but in 2023. Have a bit more patience, please. (Not inactive, Paper, just traveling.)

@MikeLewis sorry! I get impatient too often (a bad habit). Thank you!

@MikeLewis how will this resolve?

[deleted]

© Manifold Markets, Inc.Terms + Mana-only TermsPrivacyRules